Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sifan Yu

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Theranostics|May 13, 2022
Erratum: MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways: ErratumMeng Ma, Jie Dai, Huan Tang, et al.
Theranostics|March 15, 2019
MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK PathwaysMeng Ma, Jie Dai, Huan Tang, et al.
Journal of Orthopaedic Translation|July 15, 2024
Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectivesTao Xiaohui, Luyao Wang, Xin Yang, et al.
Journal of Orthopaedic Translation|June 15, 2026
Blocking interaction of sclerostin loop3 with osteoblastic LRP4 counteracts bone loss without increasing arterial stiffness during mechanical unloadingLuyao Wang, Ning Zhang, Hewen Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 24, 2025
Macrophagic Sclerostin Loop2-ApoER2 Interaction Required by Sclerostin for Cardiovascular Protective ActionLuyao Wang, Xiaohui Tao, Ning Zhang, et al.
Nature Communications|January 16, 2026
Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolismHewen Jiang, Xiaohui Tao, Sifan Yu, et al.
Nature Communications|October 3, 2024
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesityChuanxin Zhong, Nanxi Li, Shengzheng Wang, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Theranostics|May 13, 2022
Erratum: MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways: ErratumMeng Ma, Jie Dai, Huan Tang, et al.
Theranostics|March 15, 2019
MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK PathwaysMeng Ma, Jie Dai, Huan Tang, et al.
Journal of Orthopaedic Translation|July 15, 2024
Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectivesTao Xiaohui, Luyao Wang, Xin Yang, et al.
Journal of Orthopaedic Translation|June 15, 2026
Blocking interaction of sclerostin loop3 with osteoblastic LRP4 counteracts bone loss without increasing arterial stiffness during mechanical unloadingLuyao Wang, Ning Zhang, Hewen Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 24, 2025
Macrophagic Sclerostin Loop2-ApoER2 Interaction Required by Sclerostin for Cardiovascular Protective ActionLuyao Wang, Xiaohui Tao, Ning Zhang, et al.
Nature Communications|January 16, 2026
Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolismHewen Jiang, Xiaohui Tao, Sifan Yu, et al.
Nature Communications|October 3, 2024
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesityChuanxin Zhong, Nanxi Li, Shengzheng Wang, et al.
Pageof 6